Solventum Co. (NYSE:SOLV - Get Free Report) saw strong trading volume on Wednesday . 1,781,491 shares were traded during mid-day trading, an increase of 82% from the previous session's volume of 978,943 shares.The stock last traded at $68.66 and had previously closed at $69.41.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on SOLV shares. Piper Sandler lifted their target price on Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Morgan Stanley upped their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research note on Monday, November 11th. Stifel Nicolaus assumed coverage on shares of Solventum in a report on Tuesday, October 8th. They set a "buy" rating and a $82.00 price target on the stock. Wolfe Research began coverage on shares of Solventum in a research report on Thursday, September 26th. They issued a "peer perform" rating for the company. Finally, Mizuho started coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $68.29.
Get Our Latest Report on SOLV
Solventum Stock Down 0.8 %
The stock's 50-day moving average price is $69.50 and its two-hundred day moving average price is $64.66. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in SOLV. Hollencrest Capital Management purchased a new position in Solventum in the 2nd quarter valued at approximately $25,000. Modus Advisors LLC purchased a new position in shares of Solventum in the fourth quarter valued at $25,000. Copeland Capital Management LLC bought a new stake in shares of Solventum during the 3rd quarter valued at $26,000. Mather Group LLC. purchased a new stake in Solventum during the 3rd quarter worth about $27,000. Finally, Studio Investment Management LLC purchased a new stake in Solventum during the 2nd quarter worth about $29,000.
About Solventum
(
Get Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
See Also
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
